PC
PanTHERA CryoSolutions develops patented ice recrystallization inhibitor (IRI) technology that enhances cryopreservation of cells, tissues, and organs, significantly improving post-thaw recovery and functionality. This technology reduces reliance on liquid nitrogen, enabling more cost-effective storage and transportation solutions for cell therapy applications.
Updated 4 months ago
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- PanTHERA CryoSolutions develops patented ice recrystallization inhibitor (IRI) technology that enhances cryopreservation of cells, tissues, and organs, significantly improving post-thaw recovery and functionality. This technology reduces reliance on liquid nitrogen, enabling more cost-effective storage and transportation solutions for cell therapy applications.